Catalyst Wire Dossier Catalyst Wire Dossier

NNC0195-0092 (Somapacitan)

somapacitan · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC0195-0092 (Somapacitan), covering 2020-07-07 to 2020-07-07. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency. [Phase 3]

See pricing